定量原发肿瘤吲哚菁绿测量预测小鼠模型骨肉瘤肺转移负荷
研究在免疫健全的原位小鼠骨肉瘤模型中,用吲哚菁绿荧光血管造影定量原发肿瘤和肺转移。可见或可触及肿瘤的小鼠后肢荧光高于检查阴性者,原发肿瘤荧光与肺荧光呈强线性趋势,但与CT肿瘤体积无相关性。作者认为ICG近红外荧光成像有作为临床前概念验证手段的潜在价值。
要点
- 可见或可触及肿瘤小鼠后肢荧光为3.5±2.3 APU,检查阴性者为0.71±0.38 APU,差异有统计学意义。
- 原发肿瘤荧光与肺荧光呈强线性趋势(r=0.81,p<0.01),提示与原发肿瘤荧光与转移负荷直接相关。
- 原发肿瘤归一化荧光与CT体积测量无相关性(r=0.04,p=0.45)。
核心结论
- 在既往验证的免疫健全原位小鼠模型中,ICG血管造影可定量原发和转移性骨肉瘤。
- 原发肿瘤ICG荧光定量与转移负荷呈线性相关,而该关系与临床肿瘤大小无关。
- 这凸显ICG近红外荧光成像作为有价值的临床前概念验证手段的潜在用途。
- 未来实验工作将用该模型评估新型骨肉瘤小分子抑制剂的疗效。
研究设计与样本
- 六组4至6周龄免疫健全Balb/c小鼠(每组n=6),向左后肢胫骨近端骺旁注射数量不等的K7M2小鼠骨肉瘤细胞。
- 注射后4周行后肢经股骨截肢,注射后10周处死并取肺。
- 肺和原发肿瘤标本的组织学检查证实ICG仅定位于瘤床内。
主要发现
- 可见或可触及肿瘤生长的小鼠后肢荧光为3.5±2.3任意灌注单位(APU),高于检查阴性小鼠的0.71±0.38 APU(平均差-2.7±0.5,95%CI -3.7至-1.8,p<0.001)。
- 原发肿瘤与肺荧光之间观察到强线性趋势(r=0.81,p<0.01),提示定量ICG肿瘤荧光与最终转移负荷直接相关。
- 归一化原发肿瘤荧光与CT体积测量之间未发现相关性(r=0.04,p=0.45)。
关键数值与推荐
- APU定义为经检测器归一化的荧光像素回返值。
- 可见或可触及肿瘤组后肢荧光3.5±2.3 APU vs 检查阴性组0.71±0.38 APU,平均差-2.7±0.5(95%CI -3.7至-1.8,p<0.001)。
- 原发肿瘤与肺荧光线性趋势r=0.81,p<0.01。
- 归一化原发肿瘤荧光与CT体积测量r=0.04,p=0.45。
临床怎么用
- 鉴于ICG仅组织学定位于瘤床,作者设想ICG血管造影的临床用途为术中边缘和肿瘤检测器。
- 作者认为该工具可作为术中组织学的替代方法,用于确认原发肿瘤切缘阴性,或作为脆弱解剖部位减瘤手术的有价值工具。
- 由于已证明冷冻肿瘤样本中ICG成功保留,未来工作将聚焦于在观察性人体试验中对该模态进行盲法验证,比较收获组织样本的ICG荧光与新鲜冷冻病理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current preclinical osteosarcoma (OS) models largely focus on quantifying primary tumor burden. However, most fatalities from OS are caused by metastatic disease. The quantification of metastatic OS currently relies on CT, which is limited by motion artifact, requires intravenous contrast, and can be technically demanding in the preclinical setting. We describe the ability for indocyanine green (ICG) fluorescence angiography to quantify primary and metastatic OS in a previously validated orthotopic, immunocompetent mouse model. QUESTIONS/PURPOSES: (1) Can near-infrared ICG fluorescence be used to attach a comparable, quantitative value to the primary OS tumor in our experimental mouse model? (2) Will primary tumor fluorescence differ in mice that go on to develop metastatic lung disease? (3) Does primary tumor fluorescence correlate with tumor volume measured with CT? METHODS: Six groups of 4- to 6-week-old immunocompetent Balb/c mice (n = 6 per group) received paraphyseal injections into their left hindlimb proximal tibia consisting of variable numbers of K7M2 mouse OS cells. A hindlimb transfemoral amputation was performed 4 weeks after injection with euthanasia and lung extraction performed 10 weeks after injection. Histologic examination of lung and primary tumor specimens confirmed ICG localization only within the tumor bed. RESULTS: Mice with visible or palpable tumor growth had greater hindlimb fluorescence (3.5 ± 2.3 arbitrary perfusion units [APU], defined as the fluorescence pixel return normalized by the detector) compared with those with a negative examination (0.71 ± 0.38 APU, -2.7 ± 0.5 mean difference, 95% confidence interval -3.7 to -1.8, p < 0.001). A strong linear trend (r = 0.81, p < 0.01) was observed between primary tumor and lung fluorescence, suggesting that quantitative ICG tumor fluorescence is directly related to eventual metastatic burden. We did not find a correlation (r = 0.04, p = 0.45) between normalized primary tumor fluorescence and CT volumetric measurements. CONCLUSIONS: We demonstrate a novel methodology for quantifying primary and metastatic OS in a previously validated, immunocompetent, orthotopic mouse model. Quantitative fluorescence of the primary tumor with ICG angiography is linearly related to metastatic burden, a relationship that does not exist with respect to clinical tumor size. This highlights the potential utility of ICG near-infrared fluorescence imaging as a valuable preclinical proof-of-concept modality. Future experimental work will use this model to evaluate the efficacy of novel OS small molecule inhibitors. CLINICAL RELEVANCE: Given the histologic localization of ICG to only the tumor bed, we envision the clinical use of ICG angiography as an intraoperative margin and tumor detector. Such a tool may be used as an alternative to intraoperative histology to confirm negative primary tumor margins or as a valuable tool for debulking surgeries in vulnerable anatomic locations. Because we have demonstrated the successful preservation of ICG in frozen tumor samples, future work will focus on blinded validation of this modality in observational human trials, comparing the ICG fluorescence of harvested tissue samples with fresh frozen pathology.
引用
- Fourman MS, Mahjoub A, Mandell JB, et al. Quantitative Primary Tumor Indocyanine Green Measurements Predict Osteosarcoma Metastatic Lung Burden in a Mouse Model. Clin Orthop Relat Res. 2018. PMID: 29408832. doi:10.1007/s11999.0000000000000003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。